Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.
- DOI
- 10.1158/2643-3230.bcd-25-0477
- Published
- 2026 Jul 1
- Container
- Blood cancer discovery
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2643-3230.bcd-25-0477,
title = {Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.},
author = {Senapati J and Kantarjian HM and Ayoub E and Quesada AE and Loghavi S and Sasaki K and Kadia TM and Daver N and DiNardo CD and Jain A and McCabe M and Haddad FG and Brandt M and Tang G and Alvarado Y and Farish K and Abbas HA and Garcia-Manero G and Ravandi F and Andreeff M and Borthakur G},
year = {2026},
journal = {Blood cancer discovery},
doi = {10.1158/2643-3230.bcd-25-0477},
url = {https://doi.org/10.1158/2643-3230.bcd-25-0477}
}RIS
TY - JOUR TI - Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial. AU - Senapati J AU - Kantarjian HM AU - Ayoub E AU - Quesada AE AU - Loghavi S AU - Sasaki K AU - Kadia TM AU - Daver N AU - DiNardo CD AU - Jain A AU - McCabe M AU - Haddad FG AU - Brandt M AU - Tang G AU - Alvarado Y AU - Farish K AU - Abbas HA AU - Garcia-Manero G AU - Ravandi F AU - Andreeff M AU - Borthakur G PY - 2026 JO - Blood cancer discovery DO - 10.1158/2643-3230.bcd-25-0477 UR - https://doi.org/10.1158/2643-3230.bcd-25-0477 ER -
APA
J, S., HM, K., E, A., AE, Q., S, L., K, S., TM, K., N, D., CD, D., A, J., M, M., FG, H., M, B., G, T., Y, A., K, F., HA, A., G, G., F, R., M, A., & G, B. (2026). Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.. Blood cancer discovery. https://doi.org/10.1158/2643-3230.bcd-25-0477
Source records
- pubmed · retrieved 2026-09-26T22:44:34.263Z